- This event has passed.
PEER PERSPECTIVES: The Evolving Treatment Landscape in GISTs (Gastointestinal Stromal Tumors)
July 8 @ 6:30 pm MDTFree
Hear what the experts are saying
The traditional treatment algorithm for advanced GISTs has been imatinib as first-line therapy, sunitinib as second-line therapy, and regorafenib as third-line therapy. Now, however, the GIST treatment landscape is evolving with new therapies being added to physicians’ armamentarium. This discussion will explore the data supporting the use of new therapies and how the traditional algorithm may be changing.